Two Sigma Securities
AZR icon

Two Sigma Securities’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Two Sigma Securities’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-683
Closed -$3.76K – 1612
2025
Q4 		$3.76K Buy
683
+169
+33% +$1.37K ﹤0.01% 1355
2025
Q3 		$4.54K Buy
+514
New +$5.01K ﹤0.01% 1257
2024
Q4 		– Sell
-1,085
Closed -$27.1K – 1585
2024
Q3 		$27.1K Buy
+1,085
New +$28.3K ﹤0.01% 2444
2023
Q3 		– Sell
-33
Closed -$4.31K – 2868
2023
Q2 		$4.31K Sell
33
-45
-58% -$8.14K ﹤0.01% 2680
2023
Q1 		$17.1K Buy
78
+28
+56% +$6.79K ﹤0.01% 2383
2022
Q4 		$6.75K Buy
50
+22
+79% +$3.85K ﹤0.01% 2421
2022
Q3 		$6K Buy
+28
New +$12.6K ﹤0.01% 2460

Other funds holding AZR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Manchester Capital Management
Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Raffa Wealth Management
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Two Sigma Securities's AZR Position: Q1 2026 in Review

Two Sigma Securities sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q1 2026, closing a stake of 683 shares — an estimated $3.76K sold.

Two Sigma Securities first reported a position in AZR in Q3 2022 and held it in 7 quarters. The position peaked at $27.1K in Q3 2024. 15 funds tracked by Wall St. Rank hold AZR as of Q1 2026.

  • Two Sigma Securities reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 683 Azora Therapeutics, Inc. Common Stock shares in Q1 2026, an estimated $3.76K.
  • Two Sigma Securities first reported a position in Azora Therapeutics, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
  • Two Sigma Securities's Azora Therapeutics, Inc. Common Stock position peaked at $27.1K in Q3 2024.
  • 15 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.